|
|
||||||||
a Molecular Neurobiology Laboratory,
b Neuroregeneration Laboratory, and
c Udall Parkinson's Disease Center, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA
Key Words. Embryonic stem cells • Promoter strength • Transgene expression • In vitro differentiation
Kwang-Soo Kim, Ph.D., Molecular Neurobiology Laboratory, MRC216, McLean Hospital, Harvard Medical School, Belmont, Massachusetts 02478, USA. Telephone: 617-855-2024; Fax: 617-855-3479; e-mail: kskim{at}mclean.harvard.edu
Mouse embryonic stem (ES) cells are derived from the inner cell mass of the preimplantation embryo and have the developmental capacity to generate all cell types of the body. Combined with efficient genetic manipulation and in vitro differentiation procedures, ES cells are a useful system for the molecular analysis of developmental pathways. We analyzed and compared the transcriptional activities of a cellular polypeptide chain elongation factor 1 alpha (EF), a cellular-virus hybrid (cytomegalo-virus [CMV] immediate early enhancer fused to chicken ß-actin [CBA]), and a viral CMV promoter system in two ES cell lines. When transiently transfected, the EF and CBA promoters robustly drove reporter gene expression, while the CMV promoter was inactive. We also demonstrated that the EF and CBA promoters effectively drove gene expression in different stages of cell development: naïve ES cells, embryoid bodies (EBs), and neuronal precursor cells. In contrast, the CMV promoter did not have transcriptional activity in either ES cells or EB but had significant activity once ES cells differentiated into neuronal precursors. Our data show that individual promoters have different abilities to express reporter gene expression in the ES and other cell types tested.
This article has been cited by other articles:
![]() |
S. Parisi, F. Passaro, L. Aloia, I. Manabe, R. Nagai, L. Pastore, and T. Russo Klf5 is involved in self-renewal of mouse embryonic stem cells J. Cell Sci., August 15, 2008; 121(16): 2629 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gassanov, D. Devost, B. Danalache, N. Noiseux, M. Jankowski, H. H. Zingg, and J. Gutkowska Functional Activity of the Carboxyl-Terminally Extended Oxytocin Precursor Peptide During Cardiac Differentiation of Embryonic Stem Cells Stem Cells, January 1, 2008; 26(1): 45 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Bornkamm, C. Berens, C. Kuklik-Roos, J.-M. Bechet, G. Laux, J. Bachl, M. Korndoerfer, M. Schlee, M. Holzel, A. Malamoussi, et al. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system Nucleic Acids Res., September 7, 2005; 33(16): e137 - e137. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Shim, H.-C. Koh, M.-Y. Chang, E. Roh, C.-Y. Choi, Y. J. Oh, H. Son, Y.-S. Lee, L. Studer, and S.-H. Lee Enhanced In Vitro Midbrain Dopamine Neuron Differentiation, Dopaminergic Function, Neurite Outgrowth, and 1-Methyl-4-Phenylpyridium Resistance in Mouse Embryonic Stem Cells Overexpressing Bcl-XL J. Neurosci., January 28, 2004; 24(4): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Bartsevich, J. C. Miller, C. C. Case, and C. O. Pabo Engineered Zinc Finger Proteins for Controlling Stem Cell Fate Stem Cells, November 1, 2003; 21(6): 632 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zeng, J. Chen, J. F. Sanchez, M. Coggiano, O. Dillon-Carter, J. Petersen, and W. J. Freed Stable Expression of hrGFP by Mouse Embryonic Stem Cells: Promoter Activity in the Undifferentiated State and During Dopaminergic Neural Differentiation Stem Cells, November 1, 2003; 21(6): 647 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ward and P. L. Stern The Human Cytomegalovirus Immediate-Early Promoter is Transcriptionally Active in Undifferentiated Mouse Embryonic Stem Cells Stem Cells, September 1, 2002; 20(5): 472 - 475. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |